PubRank

H M Behre

Author PubWeight™ 75.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 1996 3.78
2 Lifespan and testosterone. Nature 1993 2.84
3 Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005 2.60
4 Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril 1998 1.98
5 The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric 2000 1.91
6 External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril 1990 1.65
7 The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric 2000 1.62
8 Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000 1.60
9 Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008 1.55
10 Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol 1996 1.53
11 Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril 1995 1.45
12 [The Kallmann syndrome. Its pathophysiology and clinical picture]. Dtsch Med Wochenschr 1994 1.39
13 Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 2004 1.33
14 Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl 2008 1.31
15 Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 2006 1.26
16 ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res 2008 1.22
17 Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) 1994 1.05
18 Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril 1997 1.05
19 Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 2005 1.04
20 Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 2005 1.03
21 Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection--prevalence, types, sex distribution and reproductive relevance. Hum Reprod 1998 1.01
22 Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene 2006 0.98
23 Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998 0.97
24 Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol 1998 0.97
25 Update on treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum Reprod 1998 0.97
26 Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 1996 0.95
27 Surgical ligation vs. angiographic embolization of the vena spermatica: a prospective randomized study for the treatment of varicocele-related infertility. Andrologia 1993 0.94
28 Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl 2008 0.94
29 Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men. Clin Endocrinol (Oxf) 1999 0.92
30 Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J Clin Endocrinol Metab 1997 0.92
31 Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum Reprod 1997 0.90
32 Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol 2005 0.89
33 Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis. Hum Reprod 1999 0.88
34 Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications. Oncogene 2006 0.86
35 Frequently subnormal semen profiles of normal volunteers recruited over 17 years. Int J Androl 1997 0.86
36 CFTR gene mutations in men with bilateral ejaculatory-duct obstruction and anomalies of the seminal vesicles. Am J Hum Genet 1997 0.86
37 Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis). Endocrinology 1991 0.85
38 Reproductive parameters of older compared to younger men of infertile couples. Int J Androl 1996 0.85
39 Pharmacokinetics and pharmacodynamics of testosterone enanthate and dihydrotestosterone enanthate in non-human primates. Acta Endocrinol (Copenh) 1990 0.85
40 Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link. Leukemia 2006 0.85
41 Low-level sex chromosome mosaicism in female partners of couples undergoing ICSI therapy does not significantly affect treatment outcome. Hum Reprod 2001 0.84
42 Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm Metab Res 2001 0.84
43 Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab 1999 0.84
44 Lack of correlation between cadmium in seminal plasma and fertility status of nonexposed individuals and two cadmium-exposed patients. Reprod Toxicol 1996 0.84
45 Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol 1998 0.83
46 Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDY1) genes from father to son through intracytoplasmic sperm injection: case report. Hum Reprod 1999 0.83
47 Clustering of male infertility in the families of couples treated with intracytoplasmic sperm injection. Hum Reprod 2000 0.83
48 High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 1994 0.83
49 A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate. Clin Chem Lab Med 1998 0.82
50 Restoration of spermatogenesis by follicle-stimulating hormone despite low intratesticular testosterone in photoinhibited hypogonadotropic Djungarian hamsters (Phodopus sungorus). Biol Reprod 1993 0.82
51 [Fertility in patients with Klinefelter syndrome (47,XXY)]. Urologe A 2011 0.82
52 Endocrine control of testicular somatic and premeiotic germ cell development in the immature testis of the primate Macaca mulatta. Eur J Endocrinol 1995 0.80
53 Pharmacokinetics of new testosterone transdermal therapeutic systems in gonadotropin-releasing hormone antagonist-suppressed normal men. Exp Clin Endocrinol Diabetes 1999 0.80
54 Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 1998 0.80
55 The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primate. Urol Res 1992 0.80
56 DNA flow cytometry of human semen. Hum Reprod 1999 0.79
57 Testosterone treatment of hypogonadal men participating in competitive sports. Andrologia 2008 0.79
58 Diagnostic value of scrotal sonography in infertile men: report on 658 cases. Andrologia 1991 0.79
59 Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes. J Urol 1998 0.79
60 Treatment of varicocele: counselling as effective as occlusion of the vena spermatica. Hum Reprod 1995 0.79
61 Peroxidase-positive round cells and microorganisms in human semen together with antibiotic treatment adversely influence the outcome of in-vitro fertilization and embryo transfer. Int J Androl 1994 0.78
62 Duration of the cycle of the seminiferous epithelium, estimated by the 5-bromodeoxyuridine technique, in laboratory and feral rats. J Reprod Fertil 1994 0.78
63 Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin. Exp Clin Endocrinol Diabetes 1999 0.77
64 Growth retardation, testicular stimulation, and increased melatonin synthesis by weak magnetic fields (50 Hz) in Djungarian hamsters, Phodopus sungorus. Biochem Biophys Res Commun 1997 0.77
65 Round spermatids from infertile men exhibit decreased protamine-1 and -2 mRNA. Hum Reprod 2001 0.77
66 Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat. Acta Endocrinol (Copenh) 1991 0.77
67 Endocrine and spermatological characteristics of 135 patients with bilateral megalotestis. Andrologia 1995 0.76
68 Influence of sperm surface antibodies on spontaneous pregnancy rates. Fertil Steril 1998 0.76
69 Potency differences in GnRH antagonists? Fertil Steril 1994 0.75
70 Ineffectiveness of kallikrein in treatment of idiopathic male infertility: a double-blind, randomized, placebo-controlled trial. Hum Reprod 1994 0.75
71 Can testosterone alone maintain the gonadotrophin-releasing hormone antagonist-induced suppression of spermatogenesis in the non-human primate? J Endocrinol 1994 0.75
72 Computerized semen analysis with sperm tail detection. Hum Reprod 1990 0.75
73 [Treatment of hypogonadism and infertility in the male. III]. Med Klin (Munich) 1990 0.75
74 [Therapy of hypogonadism and infertility]. Internist (Berl) 1993 0.75
75 Evaluation of a peripherally selective antiandrogen (Casodex) as a tool for studying the relationship between testosterone and spermatogenesis in the rat. J Steroid Biochem Mol Biol 1991 0.75
76 [Treatment of hypogonadism and infertility in the male. II]. Med Klin (Munich) 1990 0.75
77 Occlusion of the ulnar artery in a patient with severe ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 2001 0.75
78 Bio and immuno-activity of FSH in serum after intramuscular injection of highly purified urinary human FSH in normal men. Clin Endocrinol (Oxf) 1990 0.75
79 Long-term effects on testicular function of high-dose testosterone treatment for excessively tall stature. J Clin Endocrinol Metab 1996 0.75
80 The cynomolgus monkey prostate under physiological and hypogonadal conditions: an ultrasonographic study. J Urol 1997 0.75
81 Seminal sperm antibodies exhibit an unstable spontaneous course and an increased incidence of leucocytospermia. Int J Androl 1994 0.75
82 Prognostic value of male diagnostic profiles in intracytoplasmic sperm injection (ICSI). Int J Androl 1998 0.75
83 [Treatment of hypogonadism and infertility in the male. I]. Med Klin (Munich) 1990 0.75
84 The role of phosphocreatine kinase in the motility of human spermatozoa supported by different metabolic substrates. Mol Hum Reprod 1996 0.75
85 Report of the 7th European Workshop on Molecular and Cellular Endocrinology of the Testis. Mol Cell Endocrinol 1992 0.75
86 [Tamoxifen in male infertility. Analysis of a questionable therapy]. Dtsch Med Wochenschr 1996 0.75
87 Effects of gonadotropin-releasing hormone on bioactivity of follicle-stimulating hormone (FSH) and microstructure of FSH, luteinizing hormone and sex hormone-binding globulin in a testosterone-based contraceptive trial: evaluation of responders and non-responders. Eur J Endocrinol 1996 0.75
88 Non-reproductive heritable disorders in infertile couples and their first degree relatives. Hum Reprod 2000 0.75
89 [The effective therapy of the hot flashes during hormone withdrawal treatment in patients with advanced prostatic carcinoma]. Dtsch Med Wochenschr 1997 0.75
90 No evidence for uniparental disomy of the sex chromosomes in idiopathic male infertility. Mol Hum Reprod 2000 0.75
91 [Treatment of varicocele in the age of "evidence-based medicine". Medical counseling is as successful as interventional treatment (ligation or embolization)]. Urologe A 1998 0.75